Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ambica International Corporation is a prominent pharmaceutical company headquartered in the Philippines, specializing in the importation, marketing, and distribution of a diverse range of healthcare products. Since its inception in 1998, the company has established itself as a key player in the Filipino healthcare market by providing high-quality and affordable generic and branded medicines. Their extensive portfolio covers critical therapeutic areas including oncology, cardiology, gastroenterology, and infectious diseases. Ambica operates through a robust nationwide distribution network, ensuring that essential medications reach hospitals and pharmacies across the archipelago. The company is recognized for its strategic partnerships with global manufacturers and its commitment to maintaining high standards of regulatory compliance and pharmaceutical excellence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ambica International Corporation.